Walleye Trading
AMAG

Walleye Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Walleye Trading’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,627
Closed -$73.7K – 4798
2020
Q1 		$59K Buy
+9,627
New +$84.8K ﹤0.01% 3373
2019
Q1 		– Sell
-100
Closed -$2K – 5021
2018
Q4 		$2K Buy
+100
New +$1.91K ﹤0.01% 4519
2017
Q4 		– Sell
-24,919
Closed -$460 – 4772
2017
Q3 		$460 Buy
24,919
+19,519
+361% +$364K ﹤0.01% 2552
2017
Q2 		$99 Buy
+5,400
New +$107K ﹤0.01% 3558
2017
Q1 		– Sell
-11,200
Closed -$390K – 5331
2016
Q4 		$390K Buy
11,200
+9,920
+775% +$296K ﹤0.01% 2287
2016
Q3 		$31K Buy
+1,280
New +$32K ﹤0.01% 4006
2016
Q2 		– Sell
-1,900
Closed -$44K – 5893
2016
Q1 		$44K Buy
+1,900
New +$45.1K ﹤0.01% 3967
2015
Q3 		– Sell
-100
Closed -$7K – 5710
2015
Q2 		$7K Buy
+100
New +$6.29K ﹤0.01% 4425

Walleye Trading's AMAG Position: Q2 2020 in Review

Walleye Trading sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 9,627 shares — an estimated $73.7K sold.

Walleye Trading first reported a position in AMAG in Q2 2015 and held it in 8 quarters. The position peaked at $390K in Q4 2016. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • Walleye Trading reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Walleye Trading sold 9,627 AMAG Pharmaceuticals shares in Q2 2020, an estimated $73.7K.
  • Walleye Trading first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 8 quarters.
  • Walleye Trading's AMAG Pharmaceuticals position peaked at $390K in Q4 2016.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.